Xtl Biopharmaceuticals (XTLB) Profit After Tax (QoQ) (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) Profit After Tax (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -78.14% |
| Sep 30, 2024 | 391.05% |
| Jun 30, 2024 | -245.15% |
| Mar 31, 2024 | 136.47% |
| Dec 31, 2023 | -232.08% |
| Sep 30, 2023 | 376.65% |
| Jun 30, 2023 | 60.39% |
| Mar 31, 2023 | 40.13% |
| Dec 31, 2022 | -86.97% |
| Sep 30, 2022 | -188.07% |
| Jun 30, 2022 | -156.32% |
| Mar 31, 2022 | 128.49% |
| Dec 31, 2021 | -123.40% |
| Sep 30, 2021 | 30.87% |
| Jun 30, 2021 | -502.10% |
| Mar 31, 2021 | -94.08% |
| Dec 31, 2020 | 610.78% |
| Sep 30, 2020 | 14.39% |
| Jun 30, 2020 | -738.73% |
| Mar 31, 2020 | 110.92% |